文献速递主动脉疾病

胸主动脉腔内修复术后死亡与卒中风险的当代评估

Contemporary evaluation of mortality and stroke risk after thoracic endovascular aortic repair.
PubMed 文献 · J Vasc Surg · 2017-05-11

基于2013至2014年美国外科医师学会国家手术质量改进数据库的826例TEVAR患者,30天死亡率为7.63%,卒中率为4.5%。多因素分析确定6项独立危险因素并构建6分风险评分,用于术前风险分层。

要点

  • TEVAR术后30天死亡率为7.63%,卒中率为4.5%。
  • 年龄≥80岁、急诊手术、ASA>3级等6项因素独立预测30天死亡。
  • 基于6项因素构建的6分风险评分对30天死亡有较高预测能力。

核心结论

  • 近十年TEVAR术后围手术期死亡率和卒中率仍较高。
  • 基于6项术前因素构建的6分风险评分可用于TEVAR术前风险分层。

研究设计与样本

  • 回顾性队列研究,使用2013至2014年美国外科医师学会国家手术质量改进计划数据库。
  • 共纳入826例因各种主动脉疾病行TEVAR的患者。
  • 采用双变量分析筛选变量,再以术前变量进行多因素logistic回归,模型内部交叉验证。

主要发现

  • 30天死亡率为7.63%(n=63),卒中率为4.5%(n=37)。
  • 年龄≥80岁与死亡独立相关(OR 2.32,95%CI 1.25-4.31)。
  • 急诊手术与死亡独立相关(OR 2.61,95%CI 1.39-4.90)。
  • ASA分级>3与死亡独立相关(OR 2.89,95%CI 1.34-6.24)。
  • 术前72小时内输血>4单位与死亡独立相关(OR 2.86,95%CI 1.30-6.28)。

关键数值与推荐

  • 术前肌酐≥1.8 mg/dL与死亡独立相关(OR 2.07,95%CI 1.05-4.08)。
  • 术前白细胞计数≥12×10^9/L与死亡独立相关(OR 2.65,95%CI 1.41-4.96)。
  • 基于上述6项因素生成6分风险评分,对总体30天死亡率显示高预测能力。

临床怎么用

  • 可利用6分风险评分在本前对TEVAR患者进行风险分层。
  • 对高龄、急诊、ASA>3级、术前输血、肌酐升高及白细胞升高等高危因素应加强围手术期管理。

局限性

  • 回顾性数据库研究,可能存在选择偏倚和未测量混杂。
  • 风险评分仅进行内部交叉验证,需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: During the past decade, thoracic endovascular aortic repair (TEVAR) has increased as a treatment option for a variety of aortic pathologic processes. Despite this rise in the use of thoracic stent grafts, real-world outcomes from a robust, adjudicated, contemporary data set have yet to be reported. Previous studies have shown periprocedural mortality rates between 1.5% and 9.5% and procedure-related stroke rates of 2.3% to 8.2%. With advances in device engineering and increased experience of physicians, we hypothesized that the rates of these complications would be reduced in a more recent sample set. The purpose of this study was to determine current rates of mortality and stroke after TEVAR, to identify risk factors that contribute to 30-day mortality, and to develop a simple scoring system that allows risk stratification of patients undergoing TEVAR. METHODS: We examined the 30-day mortality rate after TEVAR using the 2013 to 2014 American College of Surgeons National Surgical Quality Improvement Program database. Patients undergoing TEVAR for all aortic disease were identified using procedure codes. Bivariate analyses were performed to evaluate the association of preoperative, intraoperative, and postoperative variables with 30-day mortality, followed by multivariable logistic analysis using preoperative variables only, with P < .10 as the criterion for model entry. The predictive logistic model was internally validated by cross-validation. Variables included in the multivariable model were used to develop a risk score. RESULTS: There were 826 patients included. The 30-day mortality and stroke rates were 7.63% (n = 63) and 4.5% (n = 37), respectively. In regression analysis, mortality was independently associated with age ≥80 years (odds ratio [OR], 2.32; 95% confidence interval [CI], 1.25-4.31), emergency case (OR, 2.61; 95% CI, 1.39-4.90), American Society of Anesthesiologists classification >3 (OR, 2.89; 95% CI, 1.34-6.24), transfusion >4 units in the 72 hours before surgery (OR, 2.86; 95% CI, 1.30-6.28), preoperative creatinine concentration ≥1.8 mg/dL (OR, 2.07; 95% CI, 1.05-4.08), and preoperative white blood cell count ≥12 × 109/L (OR, 2.65; 95% CI, 1.41-4.96). Incorporating these factors, a 6-point risk score was generated and demonstrated high predictability for overall 30-day mortality. CONCLUSIONS: Recent data from a national, retrospective data set demonstrate that high perioperative mortality and stroke rates have persisted during the last decade. The risk score derived from this data set is simple and convenient and serves as a prognostic tool in the preoperative risk stratification of patients being evaluated for TEVAR.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Hu FY, Fang ZB, Leshnower BG, et al. Contemporary evaluation of mortality and stroke risk after thoracic endovascular aortic repair. J Vasc Surg. 2017. PMID: 28502542. doi:10.1016/j.jvs.2017.01.069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。